ADAR and cancer: As the upregulation of BRCA1/2 synthetic lethal partners is a general feature of HR-defective cancers40, one reasonable assumption is that this higher ADAR1 expression seen in BRCA1-mutant cancers reflects the dependency these cancers have upon ADAR1 function.